Related references
Note: Only part of the references are listed.Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson's disease
Bing Cao et al.
METABOLIC BRAIN DISEASE (2022)
Air Pollution and the Risk of Parkinson's Disease: A Review
Hiromi Murata et al.
MOVEMENT DISORDERS (2022)
6-Gingerol exerts a protective effect against hypoxic injury through the p38/Nrf2/HO-1 and p38/NF-?B pathway in H9c2 cells
Xue Han et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
Meena S. Subbarayan et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Physiological Concentration of H2O2 Supports Dopamine Neuronal Survival via Activation of Nrf2 Signaling in Glial Cells
Guoqing Wang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)
Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's disease
Claudia Bento-Pereira et al.
MEDICINAL RESEARCH REVIEWS (2021)
Metabolically Activated Proteostasis Regulators Protect against Glutamate Toxicity by Activating NRF2
Jessica D. Rosarda et al.
ACS CHEMICAL BIOLOGY (2021)
Transposable elements as new players in neurodegenerative diseases
Camille Ravel-Godreuil et al.
FEBS LETTERS (2021)
Ferroptosis: mechanisms, biology and role in disease
Xuejun Jiang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Parkinson's Disease Drug Development Since 1999: A Story of Repurposing and Relative Success
Deirdre M. Boucherie et al.
JOURNAL OF PARKINSONS DISEASE (2021)
Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease
Jannik Prasuhn et al.
GENES (2021)
NRF2 Activation and Downstream Effects: Focus on Parkinson's Disease and Brain Angiotensin
Juan A. Parga et al.
ANTIOXIDANTS (2021)
Nrf2 as a potential target for Parkinson's disease therapy
Yingcai Niu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2021)
Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson?s disease: The therapeutic role of Nrf2 activators
Saravanan Jayaram et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
Association of NO2 and Other Air Pollution Exposures With the Risk of Parkinson Disease
Sungyang Jo et al.
JAMA NEUROLOGY (2021)
Parkinson's Disease Genetics and Pathophysiology
Gabriel E. Vazquez-Velez et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 44, 2021 (2021)
Parkinson's Disease-Related Genes and Lipid Alteration
Milena Fais et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases
Emilia Zgorzynska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Intersection of Parkinson's Disease, Viral Infections, and COVID-19
Benjamin Rosen et al.
MOLECULAR NEUROBIOLOGY (2021)
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson's Disease
Youcui Wang et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Nrf2 knockout altered brain iron deposition and mitigated age-related motor dysfunction in aging mice
Kang Han et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Oxidative stress factors in Parkinson's disease
Jolanta Dorszewska et al.
NEURAL REGENERATION RESEARCH (2021)
Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases
Qi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications
Linchi Rani et al.
MITOCHONDRION (2020)
Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca2+ efflux and Reactive Oxygen Species (ROS) homeostasis
Marta Cherubini et al.
NEUROBIOLOGY OF DISEASE (2020)
Molecular mechanism of curcumin action in signaling pathways: Review of the latest research
Przemyslaw Liczbinski et al.
PHYTOTHERAPY RESEARCH (2020)
Obtusaquinone: A Cysteine-Modifying Compound That Targets Keap1 for Degradation
Christian E. Badr et al.
ACS CHEMICAL BIOLOGY (2020)
Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation
Plamena R. Angelova et al.
CELL DEATH AND DIFFERENTIATION (2020)
Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
Xiaohua Song et al.
FRONTIERS IN NEUROSCIENCE (2020)
Clinical and Imaging Markers of Prodromal Parkinson's Disease
Eldbjorg Hustad et al.
FRONTIERS IN NEUROLOGY (2020)
Transcriptional activation of antioxidant gene expression by Nrf2 protects against mitochondrial dysfunction and neuronal death associated with acute and chronic neurodegeneration
Molly J. Goodfellow et al.
EXPERIMENTAL NEUROLOGY (2020)
Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
Sarah A. Scuderi et al.
ANTIOXIDANTS (2020)
The Role of Oxidative Stress in Parkinson's Disease
Kuo-Hsuan Chang et al.
ANTIOXIDANTS (2020)
Parkinson's disease is an autoimmune disease: A reappraisal
Srinivasa Reddy Bonam et al.
AUTOIMMUNITY REVIEWS (2020)
MicroRNADeregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways
Alexandra Perez-Soriano et al.
MOVEMENT DISORDERS (2020)
Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders
Lucio G. Costa et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Findings in redox biology: From H2O2to oxidative stress
Helmut Sies
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
Janine M. DeBlasi et al.
CANCERS (2020)
An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
Sarmistha Saha et al.
MOLECULES (2020)
The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease
Neelam Sharma et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta M. Riboldi et al.
CELLS (2019)
Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator
Ji Won Choi et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis
Ai-Ling Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
Isabella Russo et al.
NEUROBIOLOGY OF DISEASE (2019)
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Leda Mezzaroba et al.
NEUROTOXICOLOGY (2019)
Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease
Natasa Kustrimovic et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy
Ji Won Choi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Nrf2: Molecular and epigenetic regulation during aging
A. Silva-Palacios et al.
AGEING RESEARCH REVIEWS (2018)
NMR study on the stabilization and chiral discrimination of sulforaphane enantiomers and analogues by cyclodextrins
Rocio Recio et al.
CARBOHYDRATE POLYMERS (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Discovery of a head-to-tail cyclic peptide as the Keapl-Nrf2 protein-protein interaction inhibitor with high cell potency
Meng-Chen Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Sulforaphane attenuates postnatal proteasome inhibition and improves spatial learning in adult mice
Aditya Sunkaria et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)
RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis
Zhentao Yang et al.
NATURE CELL BIOLOGY (2018)
Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors
Benjamin G. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models
Kyu-Sun Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death
Zhi-Shan Tu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
Karamjeet Kaur et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Dysregulation of the Causative Genes for Hereditary Parkinsonism in the Midbrain in Parkinson's Disease
Yun Joong Kim et al.
MOVEMENT DISORDERS (2017)
Epidemiology, environmental risk factors and genetics of Parkinson's disease
Anna Delamarre et al.
PRESSE MEDICALE (2017)
RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome
Yingying Zhang et al.
NATURE COMMUNICATIONS (2017)
Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism
Rong Wang et al.
AGING CELL (2017)
Neuropsychiatric manifestations of Parkinson's disease
Rosa M. Molina Ruiz et al.
Australasian Psychiatry (2016)
Parkinson's disease: Autoimmunity and neuroinflammation
Armando De Virgilio et al.
AUTOIMMUNITY REVIEWS (2016)
Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity
Chin-Hsien Lin et al.
HUMAN MOLECULAR GENETICS (2016)
Structural basis of Keap1 interactions with Nrf2
Peter Canning et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)
Hawa N. Siti et al.
VASCULAR PHARMACOLOGY (2015)
Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy
Ryan C. McCarthy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
Heather E. Allen Reish et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Novel protein-protein interaction inhibitor of Nrf2-Keap1 discovered by structure-based virtual screening
Hao-Peng Sun et al.
MEDCHEMCOMM (2014)
Lipid Peroxidation Product 4-Hydroxy-2-Nonenal Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of α-Synuclein
Eun-Jin Bae et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity
Qing He et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
The VPS35 gene and Parkinson's disease
Hao Deng et al.
MOVEMENT DISORDERS (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
Brian N. Chorley et al.
NUCLEIC ACIDS RESEARCH (2012)
A novel strategy to activate cytoprotective genes in the injured brain
Jing Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders
Eric Mills et al.
FUTURE MEDICINAL CHEMISTRY (2010)
ROS as signalling molecules:: mechanisms that generate specificity in ROS homeostasis
Benoit D'Autreaux et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism
Kit I. Tong et al.
BIOLOGICAL CHEMISTRY (2006)
Share Paper
